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ABSTRACT The level of Ca inside the sarcoplasmic reticulum (SR) is an important determinant of functional activity of the Ca
release channel/ryanodine receptor (RyR) in cardiac muscle. However, the molecular basis of RyR regulation by luminal Ca
remains largely unknown. In the present study, we investigated the potential role of the cardiac SR luminal auxiliary proteins
calsequestrin (CSQ), triadin 1, and junctin in forming the luminal calcium sensor for the cardiac RyR. Recordings of single RyR
channels incorporated into lipid bilayers, from either SR vesicle or puriﬁed RyR preparations, were performed in the presence of
MgATP using Cs1 as the charge carrier. Raising luminal [Ca] from 20 mM to 5 mM increased the open channel probability (Po)
of native RyRs in SR vesicles, but not of puriﬁed RyRs. Adding CSQ to the luminal side of the puriﬁed channels produced no
signiﬁcant changes in Po, nor did it restore the ability of RyRs to respond to luminal Ca. When triadin 1 and junctin were added
to the luminal side of puriﬁed channels, RyR Po increased signiﬁcantly; however, the channels still remained unresponsive to
changes in luminal [Ca]. In RyRs reassociated with triadin 1 and junctin, adding luminal CSQ produced a signiﬁcant decrease in
activity. After reassociation with all three proteins, RyRs responded to rises of luminal [Ca] by increasing their Po. These results
suggest that a complex of CSQ, triadin 1, and junctin confer RyR luminal Ca sensitivity. CSQ apparently serves as a luminal Ca
sensor that inhibits the channel at low luminal [Ca], whereas triadin 1 and/or junctin may be required to mediate interactions of
CSQ with RyR.
INTRODUCTION
The cardiac sarcoplasmic reticulum (SR) Ca release channel/
ryanodine receptor (RyR) is a multimolecular signaling
complex that plays a key role in excitation-contraction
coupling. During excitation-contraction coupling, the Ca that
enters the cytosol via plasmalemmal voltage-dependent Ca
channels binds to and activates RyRs at high-afﬁnity
cytosolic Ca activation sites (Meissner et al., 1997; Li and
Chen, 2001). When RyR channels open, a much larger
amount of Ca is released to the myoplasm, leading to
activation of contractile proteins. This mechanism is known
as Ca-induced Ca release (CICR) (Fabiato, 1985; Bers,
2002). Besides the high-afﬁnity cytosolic activation sites, the
RyR channel is positively controlled by low-afﬁnity Ca
sensing sites accessible from the luminal side of the channel
(Lukyanenko et al., 1996; Gyo¨rke and Gyo¨rke, 1998; Ching
et al., 2000). Dissociation of Ca from these sites on decline of
intra-SR [Ca] ([Ca]SR) leads to RyR deactivation and robust
termination of CICR, permitting cardiac relaxation (Ter-
entyev et al., 2002). RyRs, sensitive to levels of Ca in the SR,
also render a luminal Ca-dependent leak pathway that plays
an important role in setting the SR Ca content and in shaping
the response of cardiac cells to various inotropic inﬂuences
that affect the Ca release or uptake mechanisms (Lukya-
nenko et al., 2001; Shannon, et al., 2002). Abnormal regula-
tion of RyRs by luminal Ca has been implicated in certain
pathological states, including Ca overload, arrhythmia, and
heart failure (Gyo¨rke et al., 2002; Terentyev et al., 2003).
Although signiﬁcant progress has been made in elucidat-
ing the molecular basis of RyR activation by cytosolic Ca
(Meissner et al., 1997; Li and Chen, 2001), the molecular
mechanisms of luminal Ca sensing remain unknown. One
possibility is that the luminal calcium sensor is a part of the
RyR protein itself. Alternatively, auxiliary proteins in the
heart with luminal localization, such as calsequestrin (CSQ),
triadin 1, and junctin, could mediate the effects of luminal Ca
on RyR (Ikemoto et al., 1989; Donoso et al., 1995; Zhang
et al., 1997; Shin et al., 2000). Cardiac CSQ is a major Ca
binding protein in the SR lumen (Scott et al., 1988; Jones
et al., 1998) that undergoes conformational changes upon Ca
binding (Mitchell et al., 1988) and interacts with RyR either
directly (Herzog et al., 2000) or via triadin 1 and junctin
(Zhang et al., 1997). Functional studies of RyR modulation
by CSQ, mostly conducted with the skeletal muscle isoform,
have yielded controversial results. In lipid bilayer studies,
adding skeletal muscle CSQ to the luminal side of RyR has
been reported to either increase (Kawasaki and Kasai, 1994;
Ohkura et al., 1998; Szegedi et al., 1999) or decrease skeletal
muscle RyR activity (Beard et al., 2002). Understanding of
the role of CSQ as the potential luminal Ca sensor for RyR is
further complicated by the fact that high luminal Ca
concentrations that lead to maximal RyR potentiation are
also known to dissociate CSQ from the RyR complex (Zhang
et al., 1997).
Triadin 1 (Kobayashi and Jones, 1999) and junctin (Jones
et al., 1995) are transmembrane proteins that form quaternary
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complexes between themselves, RyR, and CSQ (Zhang et al.,
1997; Kobayashi and Jones, 1999; Jones et al., 1995;
Kobayashi et al., 2000). The structures of both triadin 1 and
junctin have luminal domains with areas of highly dense,
charged amino acid residues that could form the putative
luminal Ca receptor (Kobayashi and Jones, 1999; Jones et al.,
1995; Kobayashi et al., 2000). Alternatively, these proteins
could be involved in luminal Ca sensing by mediating
interactions between RyR and CSQ (Zhang et al., 1997). In
this study, we examined the impact of puriﬁcation of canine
cardiac RyR and the effects of subsequent reassociation of
the puriﬁed channel with canine cardiac CSQ, triadin 1, and
junctin on the functional activity of the RyR channel and its
ability to sense luminal Ca. The results show that a complex
of CSQ, triadin 1, and/or junctin confers luminal Ca
sensitivity to RyR. CSQ apparently serves as a luminal Ca
sensor that inhibits RyR channel activity at low luminal [Ca];
furthermore, triadin 1 and/or junctin are stimulatory by
themselves and are required to mediate the inhibitory in-
teractions between CSQ and the RyR channel.
MATERIALS AND METHODS
Single RyRs were reconstituted by fusing canine heavy SR microsomes into
planar lipid bilayers as described previously (Gyo¨rke and Gyo¨rke, 1998).
Bilayers were composed of 80% phosphatidylethanolamine and 20%
phosphatidylcholine dissolved in decane at a ﬁnal concentration of 50 mg/
ml. Channel incorporation was performed in solutions containing (in mM)
350 CsCH3SO3, 0.02 CaCl2, and 20 Hepes (pH 7.4), on the cis (cytosolic)
side of the bilayer, and 20 CsCH3SO3, 0.02 CaCl2, and 20 Hepes (pH 7.4) on
the trans (luminal) side of the bilayer. The experimental solutions contained
(in mM) 350 CsCH3SO3, 3 MgATP, 0.6 MgCl2 (free [Mg
21] ;0.9 mM),
0.02 CaCl2, and 20 Hepes, pH 7.4 (cis), and 350 CsCH3SO3, 0.02 CaCl2,
and 20 Hepes, pH 7.4 (trans). The holding potential in all experiments was
140 mV. Single channel currents were recorded with an Axopatch 200A
(Axon Instruments, Foster City, CA) patch-clamp ampliﬁer. Acquisition and
analysis of data were performed using pClamp 6.01 software (Axon
Instruments). Data are presented as mean6 SE. Paired or unpaired data sets
were statistically evaluated using a Student’s t-test or a Mann-Whitney U test
(P\ 0.05), as appropriate. Canine cardiac RyRs were puriﬁed from SR
vesicles using methods of Lai et al. (1988) and Zhang et al. (1997). These
methods yield samples of puriﬁed RyRs that do not contain junctin, triadin,
and calsequestrin (Zhang et al., 1997; Beard et al., 2002). Recombinant
puriﬁed canine cardiac calsequestrin (Kobayashi et al., 2000), junctin
(Zhang et al., 1997), and triadin 1 (Kobayashi and Jones, 1999) were
obtained as described. To test the effects of calsequestrin, junctin, and triadin
1 on the RyR channel activity, the puriﬁed proteins were added to the trans
chamber at concentrations of 5–20 mg/ml. CSQ was stored and added from
a buffer solution containing 20 mM Mops, 150 mM NaCl (pH 7.0), and ;3
mg/ml of the protein; the solutions containing triadin 1 and junctin (;–1.0
mg/ml) included 1% CHAPS, 0.8 M NaCl, and 20 mM Mops (pH 7.2).
RESULTS
Canine cardiac SR microsomes and puriﬁed RyRs recon-
stituted into proteoliposomes were fused into planar lipid
bilayers and single-channel currents were recorded with Cs1
as the charge carrier in the presence of cytosolic Mg21 and
ATP. We considered two possibilities for the luminal Ca
sensor location: 1), Ca binds either directly to the luminal
aspect of the RyR protein; or 2), Ca binds to an auxiliary
protein with a luminal location. First, to investigate the
possibility that the luminal Ca sensor is located on the RyR
protein itself, we compared the abilities to respond to
changes in luminal [Ca] of native RyRs in SR vesicles and of
puriﬁed RyRs. Channel activity was recorded at cis [Ca]
levels of 6 mM, and the luminal (trans) [Ca] was increased
from 20 mM to 5 mM. Consistent with previous studies
(Gyo¨rke and Gyo¨rke, 1998), the native RyRs responded with
a dramatic increase in Po; however, the puriﬁed RyRs
showed negligible difference in channel activity upon
increasing luminal Ca concentration. Traces of native and
FIGURE 1 Responsiveness of native and puriﬁed RyRs to increasing
luminal Ca. Representative traces of current recordings from a native (A) and
a puriﬁed (B) RyR before and after increasing [Ca] in the trans chamber
from 20 mM to 5 mM. Current recordings were obtained at140 mV holding
potential in symmetrical 350 mM CsCH3SO3, pH 7.4. The cis [Ca] was
6 mM. Channel openings are upward. (C) Pooled Po for conditions of low
and high trans [Ca] in native and puriﬁed RyRs. Data presented as mean 6
SE; n ¼ 14 and 8 for native and puriﬁed channels, respectively.
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puriﬁed controls (Fig. 1, A I and B III, respectively) as well as
the activity upon luminal [Ca] increase can be seen in Fig. 1
(native and puriﬁed luminal traces in Fig. 1, A II and B IV,
respectively). Pooled data for these conditions show that the
native RyR channel activity increased from a Po of;0.08 to
a Po of ;0.40, whereas the puriﬁed channels remained
virtually unaffected from a Po of ;0.12 to;0.15 (Fig. 1 C).
These results suggested that the luminal Ca sensor is not
located on the RyR protein itself, but may be part of
a complex of luminal proteins that were lost during the
puriﬁcation process.
Cardiac RyRs localized to the junctional SR appear to
complex with a number of proteins, including CSQ, triadin
1, and junctin, at the luminal side of the SR membrane
(Ikemoto et al., 1989; Zhang et al., 1997). To explore the
potential role of these proteins in mediating RyR luminal Ca
sensitivity, we examined the regulatory effects of different
combinations of puriﬁed cardiac triadin 1, junctin, and CSQ
on puriﬁed RyRs. We began our examination with the trans
addition of triadin 1 and junctin (5 mg/ml of each) to puriﬁed
RyR. Both triadin 1 and junctin have well-deﬁned hydro-
phobic domains (Kobayashi and Jones, 1999; Jones et al.,
1995), which should facilitate incorporation of these proteins
into bilayer after their addition to the solution in the trans
chamber. Cis [Ca] was 6 mM and trans [Ca] was 20 mM for
the control and the initial addition of triadin 1 and junctin
(Fig. 2 A, I and II). Then, cis [Ca] was reduced to 2 mM due
to excessive channel activity and the necessity to observe
any changes in channel activity once the luminal [Ca] was
increased (Fig. 2 A III). Next, luminal [Ca] was increased to
5 mM (Fig. 2 A IV). Initial addition of triadin 1 and junctin
showed a signiﬁcant increase in channel activity from Po of
0.11 to 0.54, but addition of 5 mM luminal Ca did not affect
channel activity (Fig. 2 B). Similar potentiatory effects on
channel Po were observed when either triadin 1 or junctin
alone was added to the trans side of puriﬁed RyRs in several
additional experiments (not shown). The increase in RyR
open probability observed with these proteins provided
a ‘‘functional control’’ for their association with the RyR.
Addition of the proteins to the cis side of the bilayer had no
FIGURE 2 Effects of junctin and triadin 1 on
activity of puriﬁed RyRs and their ability to
respond to luminal Ca. (A) Representative
traces of current recordings from a single
puriﬁed RyR before (I) and after (II) addition
of triadin 1 (Tr) and junctin (Jn) (5 mg/ml of
each) to the trans chamber and after a sub-
sequent increase in trans [Ca] from 20 mM to
5 mM (IV). Current recordings were obtained at
140 mV holding potential in symmetrical 350
mMCsCH3SO3, pH 7.4. The cis [Ca] was 6mM
in control and after initial addition of triadin
1 and junctin; then cis [Ca] was decreased to
2 mM (III) to avoid excessive channel activity
induced by these proteins. (B) Bar graph of
pooled values of Po for the same conditions.
Data presented as mean 6 SE (n ¼ 6). (C)
Representative traces illustrating the lack of
effects of CSQ (5 mg/ml) added to the trans
chamber on RyR channel activity (n ¼ 4).
Current recordings were obtained at 140 mV
holding potential in symmetrical 350 mM
CsCh3SO3, pH 7.4. Channel openings are
upward.
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effect on channel activity (not shown). Additional experi-
ments in which CSQ alone (5 mg/ml) was added to the trans
side yielded no signiﬁcant change in Po, nor did it recover
luminal Ca sensitivity (Fig. 2 C). We interpret these results to
suggest that neither triadin 1, junctin, nor CSQ alone mediate
RyR responsiveness to luminal Ca, although triadin 1 and
junctin have a dramatic, positive regulatory effect on RyR
activity.
The second set of experiments involved addition of the
three luminal proteins from the trans side of the bilayer (5
mg/ml each of triadin 1, junctin, and CSQ). Cis [Ca] was 6
mM and trans [Ca] was 20 mM for the control and the initial
addition of triadin 1, junctin, and CSQ (Fig. 3 A, I and II).
Then, cis [Ca] was reduced to 2 mM (Fig. 3 A III). Next,
luminal [Ca] was increased to 5 mM (Fig. 3 A IV). Initial
addition of all three proteins (i.e., triadin 1, junctin, and
CSQ) produced no signiﬁcant changes in Po (Fig. 3 B).
However, strikingly, the puriﬁed channel regained its ability
to respond to elevated luminal Ca, with a signiﬁcant increase
in channel Po from ;0.05 to ;0.22 (Fig. 3 B). These results
suggested that a combination of CSQ and triadin 1 and/or
junctin is required to endow the RyR with an ability to
respond to changes in luminal Ca.
To assess the individual roles of each of the luminal
auxiliary proteins in mediating RyR responsiveness to
luminal Ca, we used a two-step protocol in which the initial
addition of triadin 1 and/or junctin to the puriﬁed RyR was
followed by subsequent addition of CSQ (5 mg/ml of each).
Cis [Ca] remained 6 mM throughout this experiment and
trans [Ca] was 20 mM for the control and initial addition of
triadin 1 and/or junctin, as well as for the subsequent
addition of CSQ (Fig. 4 A, I–III). Finally, luminal [Ca] was
increased to 5 mM (Fig. 4 A IV). Initial addition of triadin 1
and junctin again caused a signiﬁcant increase in Po from
0.12 to 0.55, whereas the subsequent addition of CSQ gave
a signiﬁcant decrease in channel activity (Po ;0.15). The
increase of trans [Ca] to 5 mM once again resulted in
a signiﬁcant increase in channel Po to ;0.45 (Fig. 4 B),
indicating that the channels were responsive to luminal Ca.
In two additional experiments triadin 1 and junctin were
added separately and both found to have effects similar to
those observed with the combination of these proteins. Thus
triadin 1 and junctin might play interchangeable roles in
mediating RyR responsiveness to luminal Ca, consistent
with the similarities between the molecular structures of
these proteins (Kobayashi and Jones, 1999; Jones et al.,
1995; Kobayashi et al., 2000). Further studies are now on the
way to provide a detailed characterization of the effects of
triadin 1 and junctin on RyR. The restoration of RyR luminal
Ca sensitivity is summarized in Fig. 5, which depicts the
percentage of change compared to the control Po for each
combination of proteins used in these experiments.
An interesting aspect of our results is that CSQ inhibited
the activity of RyR complexed with triadin and junctin, an
effect that appeared to be reversed by increased luminal Ca
(Fig. 4). To test if low luminal Ca is a necessary requirement
for the inhibitory action of CSQ on RyR channel associated
with triadin 1 and junctin, we carried out experiments in
which CSQ was added after trans [Ca] had been raised to 5
mM. As shown in Fig. 6 A, under these conditions CSQ
failed to produce any signiﬁcant effects on channel activity.
This result is consistent with the notion that luminal Ca acts
by relieving the inhibitory inﬂuence of CSQ, possibly by
dissociation of CSQ from the RyR channel.
FIGURE 3 Effects of combined addition
of junctin, triadin 1, and calsequestrin on
activity of puriﬁed RyRs and their ability to
respond to luminal Ca. (A) Representative
traces of current recordings from a single
puriﬁed RyR before (I) and after (II)
simultaneous addition of triadin 1, junction,
and calsequestrin (5 mg/ml of each) to the
trans chamber and after subsequent in-
crease in trans [Ca] from 20 mM to 5 mM
(IV). The cis [Ca] was 6 mM in control and
after initial addition of triadin 1 and junctin;
then cis [Ca] was decreased to 2 mM (III).
Channel openings are upward. (B) Bar
graph of pooled values of Po for the same
conditions. Data presented as mean 6 SE
(n ¼ 7).
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High [Ca] and increased ionic strength have been reported
to dissociate CSQ from RyR (Zhang et al., 1997; Beard et al.,
2002). To assess the impact of elevated Ca on RyR/triadin/
junctin-CSQ interactions under the conditions of our
experiments, we tested the reversibility of the effects of
luminal Ca on puriﬁed RyRs reassociated with triadin 1,
junctin, and CSQ and on native RyR channels in SR vesicles.
Luminal Ca was reduced by chelating the excess Ca with
EGTA. Only in two out of six native RyR channels that
responded to increases in luminal Ca were the effects of
luminal Ca found to be reversible; in the four other channels
reverting to low trans [Ca] did not restore the initial low
activity (Fig. 6 B). These results suggest that 5 mM luminal
Ca results in the loss of CSQ from most but not all of the
native RyR channels in the bilayer. Interestingly, in channels
that maintained their high activity on returning to low
luminal Ca, addition of CSQ (5 mg/ml) to the trans chamber
reduced Po to original low levels (Fig. 5 B). In puriﬁed RyRs
reassociated with triadin 1, junctin, and CSQ, the effects of
increased luminal Ca were reversible in all experiments
performed (n¼ 3) (Fig. 6 C). These results could be ascribed
to CSQ molecules present in the trans compartment
reassociating with the RyR/triadin/junctin complex.
Taken together, the results of our experiments point
toward CSQ as a luminal Ca sensor that negatively affects
RyR channel activity at low luminal [Ca] when RyR is
complexed with triadin 1 and/or junctin. This inhibitory
effect is overcome at increased luminal [Ca] as a result of Ca
binding to, and dissociation of CSQ from, the RyR.
DISCUSSION
Modulation of RyRs by Ca inside the SR has emerged as an
important control mechanism for CICR and Ca cycling in the
heart (see Gyo¨rke et al., 2002, for review). However, the
molecular basis of RyR regulation by luminal Ca remains to
be determined. In the present study, we have investigated the
molecular identity of the cardiac luminal Ca sensor by
reconstituting puriﬁed RyR together with the luminally
FIGURE 4 Effects of sequential addition
of junctin and triadin 1 and calsequestrin on
activity of puriﬁed RyRs and their ability to
respond to luminal Ca. (A) Representative
traces of current recordings from a single
puriﬁed RyR before (I) and after (II)
addition of triadin 1 and junctin (5 mg/ml
of each) to the trans chamber, after sub-
sequent addition of calsequestrin (III), and
after an increase of trans [Ca] from 20 mM
to 5 mM (IV). Current recordings were
obtained at 140 mV holding potential in
symmetrical 350 mM CsCH3SO3, pH 7.4.
The cis [Ca] was 6 mM throughout the
experiment. Channel openings are upward.
(B) Bar graph of pooled values of Po for the
same conditions. Data presented as mean6
SE (n ¼ 3).
FIGURE 5 The role of calsequestrin, junctin, and triadin 1 in conferring
the luminal Ca sensitivity of RyR. Relative changes in Po upon increasing
trans [Ca] from 20 mM to 5 mM for native RyR and for puriﬁed RyRs in the
presence of different combinations of luminal auxiliary proteins triadin 1
(Tr), junctin (Jn), and calsequestrin (CSQ) in the trans chamber. Data
presented as mean6 SE (n¼ 3 14) from experiments documented in Figs.
1–4. * P\ 0.05.
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located auxiliary proteins triadin 1, junctin, and CSQ. Our
results indicate that the luminal Ca sensitivity of RyR is
conferred by a complex of CSQ, triadin 1 and/or junctin. The
hypothesized functional interactions between these proteins
in the SR membrane are illustrated in Fig. 7. Based on our
results, we conclude that CSQ serves as the actual luminal
Ca sensor for RyR. Triadin 1 and/or junctin are required to
physically link RyR and CSQ. At the same time, they
stabilize the RyR in an increased activity mode and by this
fashion, prime the RyR channel for Ca-dependent regulation
by CSQ. When CSQ binds to triadin 1 and/or junctin, it
inhibits the activity of the RyR channel complex at low
luminal Ca concentrations. On raising luminal Ca, this
inhibition is gradually relieved as the Ca binding sites on
CSQ become increasingly occupied with Ca, leading to
weakened interactions between CSQ and triadin 1 (junctin)
and increased channel open probability; the channel be-
comes maximally active when CSQ dissociates completely
from the RyR complex at[5 mM Ca. Which of these two
possible forms of control by CSQ (i.e., changes in tightness
of binding interactions or dynamic dissociation/reassociation
from/to the RyR complex) operates inside cardiac myocytes
remains to be determined.
Our proposed scheme for functional relationships between
RyR, CSQ, triadin 1, and junctin is supported by current
views of binding interactions between these proteins within
the RyR complex (Zhang et al., 1997; Shin et al., 2000;
Kobayashi et al., 2000). Biochemical studies have shown
that triadin 1 and junctin directly bind to RyR and CSQ, thus
anchoring CSQ to the junctional membrane in proximity to
the RyR channel (Zhang et al., 1997). It has been reported
that the interaction of triadin 1 and junctin with CSQ occurs
at highly charged homologous luminal domains within the
structure of these proteins (Shin et al., 2000; Kobayashi et al.,
2000). These domains are characterized by the presence of
alternating positively and negatively charged amino acids
referred to as the KEKE motif (Zhang et al., 1997; Jones
et al., 1995; Kobayashi et al., 2000). The same luminal
domains appear to be involved in interactions of junctin and
triadin 1 with RyR (Zhang et al., 1997). The triadin-binding
domain of skeletal muscle CSQ was localized to an Asp-rich
region at the carboxyl-terminus of CSQ, a region which is
also implicated in Ca binding (Shin et al., 2000). Binding of
FIGURE 6 Modulation by calsequestrin of native RyR channels and
puriﬁed RyRs reassociated with triadin 1 and junctin. (A) Representative
single-channel traces illustrating the absence of effects on Po of CSQ in
puriﬁed RyRs reassociated with triadin 1 and junctin under conditions of
elevated luminal Ca (from 20 mM to 5 mM). The Po values were 0.43 6
0.08, 0.386 0.06, and 0.466 0.07 (n¼ 3) for low trans [Ca] (20 mM), high
trans [Ca] (5 mM), and high trans Ca 1 CSQ (5 mg/ml), respectively. (B)
Representative single-channel traces illustrating the irreversibility of the
effects of 5 mM luminal Ca and restoration of initial low activity by CSQ
added to the trans chamber in native RyRs. The Po values were 0.066 0.02,
0.36 6 0.07, 0.31 6 0.06, and 0.03 6 0.01 (n ¼ 4) for low trans [Ca] (20
mM), high trans [Ca] (5 mM), reverting to low trans [Ca] (20 mM), and
5 mg/ml trans CSQ, respectively. (C) Representative single-channel traces
illustrating the reversibility of the effects of 5 mM luminal Ca on puriﬁed
RyRs reassociated with triadin 1, junction, and calsequestrin. The Po values
were 0.096 0.03, 0.346 0.07, and 0.05 6 0.02 (n ¼ 3) for low trans [Ca]
(20 mM), high trans [Ca] (5 mM), and reverting to low trans [Ca] (20 mM),
respectively. In all experiments the cis [Ca] was 6 mM. Low luminal Ca was
restored by adding 5 mMEGTA to the trans chamber. Triadin 1, junctin, and
calsequestrin were added to the trans chamber at 5 mg/ml each. All current
recordings were obtained at 140mV holding potential in symmetrical 350
mM CsCH3S03, pH 7.4.
FIGURE 7 The hypothesized functional interactions between calseques-
trin, junctin, triadin 1, and RyR in the cardiac SR membrane. Based on our
results, we conclude that CSQ serves as luminal Ca sensor for RyR. Triadin
1 (Tr) and junctin (Jn) are required to physically link RyR and CSQ. At the
same time they stabilize RyR in an increased activity mode (1(1)). CSQ acts
by removing the potentiatory inﬂuence of triadin 1 and junctin on the RyR
channel through Ca-dependent interaction with triadin 1 and junctin (2()).
At low luminal Ca concentrations, CSQ inhibits the RyR channel complex
via strong interactions with triadin 1 and junctin (A). On elevating luminal
Ca this inhibition is gradually relieved as Ca binding sites on CSQ become
increasingly occupied with Ca and CSQ-triadin/junctin interactions weaken,
allowing stimulation of channel activity (B); the channel becomes
maximally active when CSQ dissociates from the RyR complex at [5
mM Ca (C).
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Ca to cardiac (Scott et al., 1988) and skeletal (Shin et al.,
2000) CSQ is expected to weaken the electrostatic inter-
actions between CSQ and triadin (junctin) by screening the
negatively charged interaction sites, thereby accounting for
the relief in inhibition of the Ca release channel activity by
CSQ at increased luminal Ca. At still higher concentrations,
Ca results in dissociation of CSQ from triadin 1 and junctin
(Zhang et al., 1997; Shin et al., 2000). On the other hand,
junctin and triadin 1 remain tightly bound to the RyR, in-
dependent of intraluminal Ca concentration (Zhang et al.,
1997).
Previous lipid bilayer studies on native and puriﬁed RyRs
have demonstrated that luminal Ca can affect RyR by at least
two different mechanisms. In native cardiac RyRs, it has
been found that luminal Ca acts at Ca sensing sites localized
at the luminal side of the RyR complex (Gyo¨rke and Gyo¨rke,
1998; Ching et al., 2000). Experiments on puriﬁed cardiac
and skeletal RyRs have convincingly shown that in some
cases, luminal Ca, after passing the pore, can induce RyR
openings by acting at the cytosolic activation sites instead of
inﬂuencing channel activity at luminal Ca sensing sites (Xu
and Meissner, 1998). Apparently, puriﬁcation can result in
loss of some regulatory proteins that are involved in luminal
Ca sensing. At the same time, puriﬁcation may lead to
alterations of the cytosolic Ca regulatory sites, making the
sites more accessible for activation for Ca passing through
the channel. In this study, the observed failure of puriﬁed
RyRs to respond to changes in [Ca] at the luminal side of the
protein is consistent with the notion that puriﬁcation causes
disruption of the luminal Ca regulatory sites. As to why the
channels did not exhibit changes in activity that could be
attributed to the ‘‘feed-through’’ activation from the cis side
reported in other puriﬁed RyR studies is not clear. One
possibility is that the changes to RyR activation sites depend
on the degree of puriﬁcation of RyR. It is conceivable that
harsher dissociation procedures make the channel more
prone to feed-through Ca activation since native RyR
channels in SR vesicles lack this mechanism (Lukyanenko
et al., 1996; Gyo¨rke and Gyo¨rke, 1998; Ching et al., 2000).
The difference could also be due to the fact that all our
measurements were performed in the presence of millimolar
[Mg] that may antagonize the effects of Ca passing through
the pore at the activation sites.
Several previous studies have addressed the effects of
CSQ on RyR activity using RyRs isolated from skeletal
muscle. Although in some of these studies adding skeletal
muscle CSQ to the luminal side of the channel was found to
activate RyR (Kawasaki and Kasai, 1994; Ohkura et al.,
1998; Szegedi et al., 1999), in other studies CSQ reduced
RyR activity (Beard et al., 2002). In the latter report, skeletal
muscle CSQ had no signiﬁcant effects on the puriﬁed
skeletal RyR, but reduced the activity of the native RyR in
SR membranes depleted of CSQ. Similarly, in a preliminary
study, cardiac CSQ was reported to inhibit the activity of
cardiac RyRs stripped of their CSQ by treatment with 10 mM
luminal Ca (Wang et al., 2001). Our ﬁndings are in line with
these results. Although the reasons behind the discrepancies
between different studies are not known, they could involve
differences in experimental conditions. For example, our
measurements with puriﬁed cardiac RyRs, as well as those
by Beard et al. (2002) with CSQ-extracted skeletal muscle
membranes, were performed in the presence of physiological
concentrations of ATP, whereas the other studies were
carried out with cytosolic Ca as the sole RyR activating
ligand. The effects of luminal Ca seem to require the
presence of allosteric modulators of RyR, such as ATP,
caffeine, or sulmazole (Gyo¨rke and Gyo¨rke, 1998; Ching
et al., 2000). Thus, the conditions of some studies might not
have been optimal for deﬁning the role of CSQ as a luminal
Ca sensor. Variation in the degree of puriﬁcation of RyR
could also contribute to the differences in results. Since
inhibition of RyR by CSQ occurs only in the presence of
triadin and/or junctin (Beard et al., 2002; this study), it is
possible that the RyR preparations from some of the studies
lacked these proteins. In a previous work, addition of triadin
to the cytosolic side of the skeletal RyR inhibited channel
activity (Ohkura et al., 1998). Although in our experiments
cytosolic triadin did not affect the cardiac RyR channel open
probability, potentiation of the channel speciﬁcally on
addition of luminal triadin suggests that this effect was due
to interaction of the protein with the putative intraluminal
triadin-binding domain of the RyR (Zhang et al., 1997).
In conclusion, our results determine, for the ﬁrst time, the
identities and modes of interactions of molecules involved in
luminal Ca regulation of single cardiac RyR channels. The
levels of luminal Ca are sensed by CSQ; then, this
information is transmitted to RyR via the intermediate
proteins, triadin 1 and/or junctin (Fig. 7). The regulation
consists of a luminal Ca-dependent relief of inhibition that
Ca-free CSQ exerts on the activity of the RyR channel
complexed with triadin 1 and junctin. This dynamic, Ca-
dependent modulation of RyR by CSQ has important
ramiﬁcations for SR Ca handling in cardiac myocytes.
Before the onset of Ca release when the [Ca]SR is high, a large
fraction of RyRs would be in a CSQ-uninhibited mode.
During Ca release when [Ca]SR declines, the increased level
of Ca-free CSQ would result in inhibition of the RyR
channels, thereby providing a molecular mechanism for the
luminal Ca-dependent termination of Ca release in cardiac
muscle (Terentyev et al., 2002, 2003). At the same time, the
excessively large fraction of CSQ-uninhibited RyR channels
at elevated basal [Ca]SR could contribute to the increased
diastolic SR Ca leak (Lukyanenko et al., 2001; Shannon et
al., 2002) and increased frequency of spontaneous Ca sparks
and Ca waves (Cheng et al., 1996; Lukyanenko et al., 1996,
2001) under the conditions of Ca overload. Future studies
will have to deﬁne the speciﬁc structural domains involved
in the described intermolecular interactions and to verify the
roles of these interactions in controlling SR Ca release inside
living cells.
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